Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.11
-0.18-7.86%
Last update: Oct 16, 6:27 PM
$2.16
-0.13-5.68%
Genprex Inc (GNPX) Stock Price, Quote, News & History
GNPXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Genprex (NASDAQ:GNPX) through any online brokerage.
Other companies in Genprex’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Genprex has a consensus price target of $11000.00.
The stock price for Genprex (NASDAQ: GNPX) is $2.16 last updated October 16, 2026 at 6:27 PM EDT.
There are no upcoming dividends for Genprex.
Genprex does not have any upcoming earnings scheduled.
There is no upcoming split for Genprex.
Genprex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
